NS3763
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 532370

CAS#: 70553-45-6

Description: NS3763 is a noncompetitive antagonist of GLUK5 receptor. NS3763 displays selectivity for inhibition of domoate-induced increase in intracellular calcium mediated through the GLU(K5) subtype (IC(50) = 1.6 microM) of kainate receptors compared with the GLU(K6) subtype (IC(50) > 30 microM). NS3763 inhibits the GLU(K5)-mediated response in a noncompetitive manner. NS3763 selectively inhibits l-glutamate- and domoate-evoked currents through GLU(K5) receptors in HEK293 cells.


Chemical Structure

img
NS3763
CAS# 70553-45-6

Theoretical Analysis

MedKoo Cat#: 532370
Name: NS3763
CAS#: 70553-45-6
Chemical Formula: C22H16N2O6
Exact Mass: 404.10
Molecular Weight: 404.378
Elemental Analysis: C, 65.35; H, 3.99; N, 6.93; O, 23.74

Price and Availability

Size Price Availability Quantity
500mg USD 3450 2-3 months
1g USD 4650 2-3 months
2g USD 7450 2-3 months
Bulk inquiry

Synonym: NS3763; NS 3763; NS-3763.

IUPAC/Chemical Name: 4,6-dibenzamidobenzene-1,3-dicarboxylic acid

InChi Key: UUDYZUDTQPLDDP-UHFFFAOYSA-N

InChi Code: InChI=1S/C22H16N2O6/c25-19(13-7-3-1-4-8-13)23-17-12-18(16(22(29)30)11-15(17)21(27)28)24-20(26)14-9-5-2-6-10-14/h1-12H,(H,23,25)(H,24,26)(H,27,28)(H,29,30)

SMILES Code: O=C(C1=C(NC(C2=CC=CC=C2)=O)C=C(NC(C3=CC=CC=C3)=O)C(C(O)=O)=C1)O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: NS3763 is a selective and noncompetitive GLUK5 receptor antagonist with an IC50 of 1.6 µM.
In vitro activity: In functional assays in human embryonic kidney (HEK)293 cells expressing homomeric GLU(K5) or GLU(K6) receptors, NS3763 is shown to display selectivity for inhibition of domoate-induced increase in intracellular calcium mediated through the GLU(K5) subtype (IC(50) = 1.6 microM) of kainate receptors compared with the GLU(K6) subtype (IC(50) > 30 microM). NS3763 inhibits the GLU(K5)-mediated response in a noncompetitive manner and does not inhibit [(3)H]alpha-amino-3-hydroxy-5-tertbutylisoxazole-4-propionic acid binding to GLU(K5) receptors. Reference: J Pharmacol Exp Ther. 2004 Jun;309(3):1003-10. https://pubmed.ncbi.nlm.nih.gov/14985418/
In vivo activity: TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 404.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: Christensen JK, Varming T, Ahring PK, Jørgensen TD, Nielsen EØ. In vitro characterization of 5-carboxyl-2,4-di-benzamidobenzoic acid (NS3763), a noncompetitive antagonist of GLUK5 receptors. J Pharmacol Exp Ther. 2004 Jun;309(3):1003-10. doi: 10.1124/jpet.103.062794. Epub 2004 Feb 25. PMID: 14985418.
In vitro protocol: Christensen JK, Varming T, Ahring PK, Jørgensen TD, Nielsen EØ. In vitro characterization of 5-carboxyl-2,4-di-benzamidobenzoic acid (NS3763), a noncompetitive antagonist of GLUK5 receptors. J Pharmacol Exp Ther. 2004 Jun;309(3):1003-10. doi: 10.1124/jpet.103.062794. Epub 2004 Feb 25. PMID: 14985418.
In vivo protocol: TBD

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Lv Q, Liu Y, Han D, Xu J, Zong YY, Wang Y, Zhang GY. Neuroprotection of GluK1 kainate receptor agonist ATPA against ischemic neuronal injury through inhibiting GluK2 kainate receptor-JNK3 pathway via GABA(A) receptors. Brain Res. 2012 May 25;1456:1-13. doi: 10.1016/j.brainres.2012.03.050. Epub 2012 Mar 28. PubMed PMID: 22516108.

2: Qi SH, Liu Y, Wang WW, Wang M, Zhang GY. Neuroprotection of ethanol against cerebral ischemia/reperfusion induced brain injury through GABA receptor activation. Brain Res. 2009 Jun 18;1276:151-8. doi: 10.1016/j.brainres.2009.04.040. Epub 2009 May 3. PubMed PMID: 19406109.

3: Xu J, Liu Y, Zhang GY. Neuroprotection of GluR5-containing kainate receptor activation against ischemic brain injury through decreasing tyrosine phosphorylation of N-methyl-D-aspartate receptors mediated by Src kinase. J Biol Chem. 2008 Oct 24;283(43):29355-66. doi: 10.1074/jbc.M800393200. Epub 2008 Aug 4. PubMed PMID: 18678878; PubMed Central PMCID: PMC2662022.

4: Platel JC, Heintz T, Young S, Gordon V, Bordey A. Tonic activation of GLUK5 kainate receptors decreases neuroblast migration in whole-mounts of the subventricular zone. J Physiol. 2008 Aug 15;586(16):3783-93. doi: 10.1113/jphysiol.2008.155879. Epub 2008 Jun 19. PubMed PMID: 18565997; PubMed Central PMCID: PMC2538932.

5: Christensen JK, Paternain AV, Selak S, Ahring PK, Lerma J. A mosaic of functional kainate receptors in hippocampal interneurons. J Neurosci. 2004 Oct 13;24(41):8986-93. PubMed PMID: 15483117.

6: Christensen JK, Varming T, Ahring PK, Jørgensen TD, Nielsen EØ. In vitro characterization of 5-carboxyl-2,4-di-benzamidobenzoic acid (NS3763), a noncompetitive antagonist of GLUK5 receptors. J Pharmacol Exp Ther. 2004 Jun;309(3):1003-10. Epub 2004 Feb 25. PubMed PMID: 14985418.